Microcosting implementation facilitation for emergency department-initiated buprenorphine for untreated opioid use disorder
The microcosting analysis revealed the resources and costs involved in implementing ED-initiated buprenorphine programs at various sites. Understanding the different ways each site customized the IF strategy can improve adoption to this initiative. Interpreting the costs during the intervention and what it takes to sustain it will help decision makers address uncertainty and promote increased acceptance of implementing these practices in the context of potential benefits that this approach can provide.
Authors
- Kathryn F. Hawk (ORCID: https://orcid.org/0000-0001-7435-5945)
- Gail D’Onofrio (ORCID: https://orcid.org/0000-0002-3833-1871)
- Edouard Coupet (ORCID: https://orcid.org/0000-0001-5460-5732)
- Eva Jennifer Edelman (ORCID: https://orcid.org/0000-0002-9375-0489)
- Patrick G. O’Connor (ORCID: https://orcid.org/0000-0002-3296-8644)
- Ali Jalali (ORCID: https://orcid.org/0000-0003-4349-1519)
- Thanh Lu (ORCID: https://orcid.org/0000-0002-5707-0339)
- David A. Fiellin (ORCID: https://orcid.org/0000-0002-4006-010X)
- Sean M. Murphy (ORCID: https://orcid.org/0000-0001-9104-0670)
- Danielle Ryan (ORCID: https://orcid.org/0000-0002-8423-3332)
- Patricia H. Owens
Institutions
- RTI International (US)
- Cornell University (US)
- Yale University (US)
- Yale New Haven Health System (US)
- Weill Cornell Medicine (US)
Publication Details
- Journal
- The American Journal of Emergency Medicine
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1016/j.ajem.2025.08.002
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute on Drug Abuse